SUNNYVALE, Calif., Nov. 10, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that innovations in hardware and software solutions and clinical data presented at this year's ASTRO (American Society for Radiation Oncology) Annual Meeting continue to support the use of the company's CyberKnife® and TomoTherapy® platforms, including the next-generation Radixact® System, to deliver (ultra) hypofractionated radiation treatments. Hypofractionated radiotherapy — a shorter course of radiotherapy with higher radiation doses per fraction — provides an efficient and effective treatment option for an increasing number of indications and may improve patients' clinical and financial experiences.
New Standard in Radiation Treatment Delivery
With more than a decade of clinical proof behind Synchrony® Motion Synchronization and Real-Time Adaptive Radiotherapy Technology for the CyberKnife System, Accuray brought this advanced capability to the Radixact System. The artificial intelligence (AI)-driven Synchrony technology corrects for tumors that move as a result of bodily processes, including respiration and digestion, as well as patient movement, without uncomfortable patient restraints or breath-hold techniques, or human intervention. It is the only technology to use image guidance during radiation delivery to automatically adapt and synchronize radiation treatment in real-time with the movement of the tumor. Synchrony enables the medical care team to deliver high precision, (ultra) hypofractionated radiation treatments with confidence — knowing that treatment delivery will automatically account for target movement.
No Trade-Off Sub-Millimeter Precision and Accuracy
The CyberKnife S7™ System is the next-generation CyberKnife platform, a robotic, non-invasive radiation therapy device capable of treating cancerous and benign tumors throughout the body, as well as neurological disorders. The system was built from the ground-up to provide clinicians with the speed they need for operational efficiency, without sacrificing the precision and accuracy required for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). SRS and SBRT are advanced external beam radiation treatment techniques used to deliver (ultra) hypofractionated radiation therapy. The CyberKnife S7 System, with Synchrony and the VOLO™ Optimizer, facilitates the delivery of accurate, sub-millimeter, (ultra) hypofractionated treatments to tumors throughout the body, even to targets that move, in as little as 15 minutes.
